Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
Valentina Gambacorta, Daniela Gnani, Luca Vago, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity
Can Can, Xinyu Yang, Hexiao Jia, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
Valentina Gambacorta, Stefano Beretta, Martina Ciccimarra, et al.
Cancer Discovery (2022) Vol. 12, Iss. 6, pp. 1449-1461
Open Access | Times Cited: 44
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
Jessica M. Salmon, Izabela Todorovski, Kym L. Stanley, et al.
Cancer Discovery (2022) Vol. 12, Iss. 6, pp. 1560-1579
Open Access | Times Cited: 25
Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Thierry Guillaume, Sylvain Thépot, Pierre Péterlin, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 10, pp. 839.e1-839.e6
Open Access | Times Cited: 31
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
Wenjing Xiao, Qiaodan Zhou, Xudong Wen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells
Ipek Bulut, Adam F. Lee, Buse Cevatemre, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 6014-6014
Open Access | Times Cited: 18
Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives
Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat‐Moghadam, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes
Yoshiro HIRASAKI, Atsushi Okabe, Masaki Fukuyo, et al.
Chemico-Biological Interactions (2022) Vol. 360, pp. 109936-109936
Closed Access | Times Cited: 13
Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets
Alessandro Allegra, Santino Caserta, Giuseppe Mirabile, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2392-2392
Open Access | Times Cited: 7
Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
Lixin Zhou, Qi Yao, Hui Li, et al.
Translational Cancer Research (2021) Vol. 10, Iss. 7, pp. 3364-3372
Open Access | Times Cited: 16
CircNPM1 strengthens Adriamycin resistance in acute myeloid leukemia by mediating the miR-345-5p/FZD5 pathway
Jie Ding, Xiaochun Zhang, Jianan Xue, et al.
Central European Journal of Immunology (2021) Vol. 46, Iss. 2, pp. 162-182
Open Access | Times Cited: 16
From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia
Carmelo Gurnari, Maria Teresa Voso, Jaroslaw P. Maciejewski, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 357-357
Open Access | Times Cited: 16
Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML
Wittawat Chantkran, Ya-Ching Hsieh, Daniella Zheleva, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 14
TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia
Lixin Zhou, Qi Yao, Le Ma, et al.
Translational Cancer Research (2021) Vol. 10, Iss. 12, pp. 5307-5318
Open Access | Times Cited: 13
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives
Ugo Chianese, Chiara Papulino, Wout Megchelenbrink, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 84-101
Open Access | Times Cited: 5
PaDef (Persea americana var. drymifolia), a Plant Antimicrobial Peptide, Triggers Apoptosis, and Induces Global Epigenetic Modifications on Histone 3 in an Acute Lymphoid Leukemia Cell Line
Paola Jiménez-Alcántar, Rodolfo López-Gómez, Joel E. López‐Meza, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 8
Clusterization in acute myeloid leukemia based on prognostic alternative splicing signature to reveal the clinical characteristics in the bone marrow microenvironment
Nan Zhang, Ping Zhang, Ying Chen, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia
Aroa Baragaño Raneros, Ramón María Alvargonzález Rodríguez, Aida Bernardo Flórez, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice
Dongfang Wang, Damian Kaniowski, Karol Jacek, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102268-102268
Open Access | Times Cited: 1
DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
Jatinder K. Lamba, Xueyuan Cao, Susana C. Raimondi, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 3024-3024
Open Access | Times Cited: 10
Inducement of ER Stress by PAD Inhibitor BB-Cl-Amidine to Effectively Kill AML Cells
Yanni Sun, Yanni Ma, Xiaoqing Jia, et al.
Current Medical Science (2022) Vol. 42, Iss. 5, pp. 958-965
Closed Access | Times Cited: 6
“Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia”
Stefano Ratti, Camilla Evangelisti, Sara Mongiorgi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
Effect of Gaillardin on Proliferation and Apoptosis of Acute Promyelocytic Leukemia Cell Lines, NB4 as Cancer Treatment
Mohammad Sayyadi, Alireza Moradabadi, Ali Noroozi‐Aghideh, et al.
Biointerface Research in Applied Chemistry (2020) Vol. 11, Iss. 1, pp. 7445-7452
Open Access | Times Cited: 6
Epigenetic reprogramming of plasmacytoid dendritic cells drives type I interferon-dependent differentiation of acute myeloid leukemias for therapeutic benefit
Jessica M. Salmon, Izabela Todorovski, Stephin J. Vervoort, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia
Adewale J. Ogunleye, Ekaterina Romanova, Yulia A. Medvedeva
F1000Research (2021) Vol. 10, pp. 204-204
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top